Audited Financial Results For The Quarter And Financial Year Ended 31St March 2017.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at their Meeting held on 30th May, 2017 considered and approved, interalia, the Audited Financial Results along with Audit report of the Company for the fourth quarter and year ended on 31st March, 2017.... Board Meeting On 30Th May, 2017
This is to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, the 30th day of May, 2017 at the Registered Office of the Company at 16, Community Centre, First Floor, Saket, New Delhi 110017, inter-alia to consider and approve the Audited Financial Results for the year ended on 31st March, 2017. Certificate Under Regulation- 40(9) Of SEBI (LODR) Regulations, 2015.
We are hereby submitting the Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 issued by the Practising Company Secretary for the half year ended on 31st March, 2017. This is for your kind information and records. Shareholding for the Period Ended March 31, 2017
Kothari Fermentation & Biochem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here Compliance Certificate Under Regulation 7(3) For The Half Year Ended 31.03.2017
Please find enclosed Compliance Certificate duly signed by the Compliance Officer and the Registrar & Share Transfer Agent under Regulation 7 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, are duly complied with for the half year ended 31-03-2017. This is for your kind information and record. Statement Of Deviation And Variation For The Quarter Ended 31.03.2017
We are enclosing herewith Statement of Deviation or Variation in Public Issue, Rights Issue, Preferential Issue etc under Regulation 32(1) Of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 31.03.2017. Though the same is not applicable to our Company, as there was no Rights Issue, Preferential Issue etc during the quarter ended 31.03.2017, yet the same is filed for your information and record. Statement Of Investor Grievances For The Quarter Ended 31St March, 2017.
Please find below the Quarterly Compliance Status of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation, 2015 for the Quarter Ended 31st March, 2017: Pending at the beginning: 0 Received during the quarter:1 Disposed during the quarter:1 Remaining unresolved: 0 Kindly take the above on record and acknowledge the receipt of the same. Standalone Financial Results, Limited Review Report for December 31, 2016
Kothari Fermentation & Biochem Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Kothari Fermentation & Biochem Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 14, 2017, inter alia, to consider and approve the Unaudited Financial Results for the quarter ended on December 31, 2016.As per the Company's Code of Conduct for Prevention of Insider Trading , the Trading Window for dealing in the Securities of the Company will remain closed for all Directors/Officers/ Designated... Shareholding for the Period Ended December 31, 2016
Kothari Fermentation & Biochem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here